Evidence map›Paper›PMID 24876916›Full record

Trial reportOxidative medicine and cellular longevity2014

Lipid and protein oxidation in newborn infants after lutein administration.

S Perrone, M Tei, M Longini, A Santacroce, G Turrisi, F Proietti, C Felici, A Picardi, F Bazzini, P Vasarri and 1 more

2 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Oxidative medicine and cellular longevity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02068807 phase1 / phase2completednot on this map

Evaluation of Antioxidant Activity of Oral Lutein in Preterm and Term Newborn

TypeinterventionalSponsorUniversity of SienaRan2011 to 2013Enrolled100ConditionsInfant, Newborn, Diseases, Other Lipid Storage DisordersArmsLutein drops, Glucose drops
NCT03340103 nawithdrawnnot on this mapstarted 2018, after this paper: background citation

Evaluation of the Antioxidant Activity of Lutein/Zeaxanthin Early Administered to Premature Newborns

TypeinterventionalSponsorSooft ItaliaRan2018 to 2019Enrolled0ConditionsAntioxidant Role of the Lutein in Preterm NewbornArmsLUTEIN ofta 0,5 gocce, Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Lutein and Neurodevelopment in Preterm Infants.Frontiers in neuroscience · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

S PerroneNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
M TeiNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
M LonginiNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
A SantacroceNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
G TurrisiNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
F ProiettiNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
C FeliciNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
A PicardiNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
F BazziniNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
P VasarriDivision of Neonatology, New Clinical Hospital of Prato, Via Suor Niccolina Infermiera 20, Galciana, 59100 Prato, Italy.
G BuonocoreNeonatal Care Unit, Department of Molecular and Developmental Medicine, University Hospital of Siena, Viale M. Bracci 16, 53100 Siena, Italy.
University of Siena · ITHospital of Prato · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo test the hypothesis that neonatal supplementation with lutein in the first hours of life reduces neonatal oxidative stress (OS) in the immediate postpartum period.

methodsA randomized controlled, double-blinded clinical trial was conducted among 150 newborns divided into control group, not supplemented (n = 47), and test group, supplemented with lutein on the first day postpartum (n = 103). Blood Samples were collected at birth from cord and at 48 hrs postpartum while routine neonatal metabolic screenings were taking place. Total hydroperoxide (TH), advanced oxidation protein products (AOPP), and biological antioxidant potential (BAP) were measured by spectrophotometry and data were analyzed by Wilcoxon rank sum test and by multivariate logistic regression analysis.

resultsBefore lutein supplementation, the mean blood concentrations of AOPP, TH, and BAP were 36.10 umol/L, 156.75 mmol/H2O2, and 2361.04 umol/L in the test group. After lutein supplementation, significantly higher BAP increment (0.17 ± 0.22 versus 0.06 versus ± 0.46) and lower TH increment (0.46 ± 0.54 versus 0.34 ± 0.52) were observed in the test group compared to controls.

conclusionNeonatal supplementation with lutein in the first hours of life increases BAP and reduces TH in supplemented babies compared to those untreated. The generation of free radical-induced damage at birth is reduced by lutein. This trial is registered with ClinicalTrials.gov NCT02068807.

Indexed as

Advanced Oxidation Protein ProductsAntioxidantsArea Under CurveDietary SupplementsDouble-Blind MethodFemaleHumansHydrogen PeroxideInfant, NewbornLipid PeroxidationLogistic ModelsLuteinMaleOxidative StressROC CurveSpectrophotometryAdvanced Oxidation Protein ProductsAntioxidantsHydrogen PeroxideLutein

Identifiers

PMID24876916
PMCPMC4021681
OpenAlexW2121467043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.